FDAMapNew FDA Approval: XywavThe Food and Drug Administration has just released its approval for the new drug, Xywav, in treating idiopathic hypersomnia and narcolepsy…Aug 23, 2021Aug 23, 2021
FDAMapHow Can the FDA Regulate Over 3.5 million Facilities and Establishments?For years, food establishments, farms, and food facilities have been calling on the Food and Drug Administration, to integrate its efforts…Aug 16, 2021Aug 16, 2021
FDAMapScreening Processes: Was Biogen’s screening process for their new drug, Aducanumab, problematic?As companies produce new drugs and products, they must follow FDA guidelines to ensure that they are not only safe for the patient, but…Aug 2, 2021Aug 2, 2021
FDAMapCrisis Management: How is Johnson and Johnson currently managing their crisis?It is critical that when a company experiences adverse events, they move quickly to fix the issue and resolve any public fear or worries…Jul 19, 2021Jul 19, 2021
FDAMapWhat Complications Arise in Decentralized Trials: FDAMap’s experiences with chronic kidney disease…Decentralized trials are prevalent in the biomedical community, however, considering the pandemic, they have become a central aspect of…Jul 12, 2021Jul 12, 2021
FDAMapClinical Trial: FDAMap’s steps in running an effective clinical trialWhen producing a new drug or biomedical device, it is important to run a legitimate clinical trial by applying protocols that have proven…Jul 12, 2021Jul 12, 2021